Table 2 Cox-proportional hazards models for the association of the new-onset renal function decline with Japanese MetS and clinical variables.

From: Enhanced prediction of renal function decline by replacing waist circumference with “A Body Shape Index (ABSI)” in diagnosing metabolic syndrome: a retrospective cohort study in Japan

Variables

Age (every 1 y)

Male gender

CAVI ≥ 9.0

Proteinuria

Receiving diabetes treatment

Receiving hypertension treatment

Receiving dyslipidemia treatment

Japanese WC-MetS

Japanese ABSI-MetS

Model 1

1.019 (1.009–1.029)

1.277 (1.067–1.529)*

3.415 (2.661–4.383)*

0.984 (0.669–1.446)

0.971 (0.565–1.668)

1.459 (1.154–1.845)*

1.173 (0.901–1.529)

0.718 (0.487–1.057)

–

Model 2

1.018 (1.007–1.028)*

1.307 (1.092–1.565)*

3.246 (2.530–4.166)*

0.939 (0.638–1.380)

0.891 (0.518–1.532)

1.314 (1.038–1.662)*

1.030 (0.785–1.352)

–

1.623 (1.273–2.069)*

  1. *p < 0.05, Hazards ratios (95% confidence intervals). Renal function decline is defined as eGFR<60 mL/min/1.73m2 during the 4-year study period. All confounders are included in the table.
  2. WC-MetS, conventional metabolic syndrome (MetS) diagnosed using waist circumference (WC); ABSI-MetS, MetS diagnosed using a body shape index (ABSI) instead of WC; Japanese, criteria developed by the Japanese Committee for the Diagnostic Criteria of MetS.
Back to article page